Concept of hybrid drugs and recent advancements in anticancer hybrids

AK Singh, A Kumar, H Singh, P Sonawane, H Paliwal… - Pharmaceuticals, 2022 - mdpi.com
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of
conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in …

[HTML][HTML] Imidazoles as potential anticancer agents: An update on recent studies

P Sharma, C LaRosa, J Antwi, R Govindarajan… - Molecules, 2021 - mdpi.com
Nitrogen-containing heterocyclic rings are common structural components of marketed
drugs. Among these heterocycles, imidazole/fused imidazole rings are present in a wide …

A review: Pharmacological aspects of metal based 1, 2, 4-triazole derived Schiff bases

W Zafar, SH Sumrra, ZH Chohan - European journal of medicinal chemistry, 2021 - Elsevier
Clinical reports have highlighted the radical increase of antibiotic resistance. As a result,
multidrug resistance has emerged as a serious threat to human health. Many organic …

Imidazoles as potential anticancer agents

I Ali, MN Lone, HY Aboul-Enein - MedChemComm, 2017 - pubs.rsc.org
Cancer is a black spot on the face of humanity in this era of science and technology.
Presently, several classes of anticancer drugs are available in the market, but issues such …

Quinoline–imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity

D Diaconu, V Antoci, V Mangalagiu… - Scientific Reports, 2022 - nature.com
Two new classes of hybrid quinoline–imidazole/benzimidazole derivatives (the hybrid QIBS
salts and QIBC cycloadducts) were designed and synthesized to evaluate their anticancer …

An overview of molecular hybrids in drug discovery

G Bérubé - Expert opinion on drug discovery, 2016 - Taylor & Francis
Introduction: The hybridization of biologically active molecules is a powerful tool for drug
discovery used to target a variety of diseases. It offers the prospect of better drugs for the …

Structural hybridization as a facile approach to new drug candidates

HMS Kumar, L Herrmann, SB Tsogoeva - Bioorganic & Medicinal Chemistry …, 2020 - Elsevier
Structural hybridization of preclinically and clinically validated pharmacologically active
molecules has emerged as a promising tool to develop new generations of safe and highly …

Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors

T Xu, D Sun, Y Chen, L Ouyang - European journal of medicinal chemistry, 2020 - Elsevier
Abstract mTOR (mammalian target of rapamycin), which is a serine/threonine kinase, has
been well-established as being closely correlated with the occurrence of various human …

Multi-targeted anticancer agents

W Zheng, Y Zhao, Q Luo, Y Zhang… - Current topics in …, 2017 - ingentaconnect.com
There is a great demand for the development of novel anticancer drugs, due to the
increasing morbidity and high mortality of cancer. To date, chemotherapy still plays a central …

Recent advances in biological active sulfonamide based hybrid compounds Part A: Two-component sulfonamide hybrids

R Ghomashi, S Ghomashi, H Aghaei… - Current Medicinal …, 2023 - benthamdirect.com
Sulfonamides constitute an important class of drugs, with many types of pharmacological
agents possessing antibacterial, anti-carbonic anhydrase, anti-obesity, diuretic …